Skip to content
Sign in

Business opportunities

Who each startup should sell to, sell through, build with, enter a market with or raise from, read from the whole network. Every opportunity comes with its reasoning, the evidence and a first step.

SWC 2026 Finalist

Monere Ai

Smartphone eyelid-photo AI that screens for anemia in seconds without a blood draw, aimed at low-resource care.

Open the dossier
Opportunities
5
High confidence
070% and above
Counterparts
5startups and investors
  • Distribution 2
  • Co-development 1
  • Investors 2

Distribution2

A channel or customer base to reach together

Anemia screening inside an AI primary-care OS

TIBOK runs primary care via its Eva assistant across Mauritius and soon Madagascar, accepts connected-device data and photos, and already offers no-blood-test screening (SilentCheck). NiADA as an API module adds a needle-free anemia screen to every consultation, giving Monere a live multi-country deployment and validation cohort.

40%confidence

Evidence from the records

  • “SilentCheck (22 questions, no blood test, biological age, built on Framingham, IDRS and SCORED)”
  • “First white-label distributor contract signed with C-Care Madagascar (19 November 2026), going live in January 2027 with its own Malagasy-speaking agent”
  • “NiADA app (analysis of a smartphone photo of the lower eyelid)”
If it works
A paid screening module for TIBOK and a prospective validation dataset for Monere across African/Indian Ocean populations.
First step
Schedule a call with TIBOK to scope an API pilot in Madagascar with lab-haemoglobin confirmation.

Add screening to Angolan teleconsultation

TERAMED's Baika platform offers 24/7 teleconsultation and corporate employee health in Angola, where anemia is prevalent; photo-based screening adds a measurable service to remote consultations.

15%confidence

Evidence from the records

  • “24/7 teleconsultation with general practitioners”
  • “Non-invasive”
If it works
A Lusophone African deployment for Monere; differentiating feature for TERAMED.
First step
Send TERAMED an integration brief and request a pilot in its corporate health programme.

Co-development1

An integration or joint product

Prenatal anemia screening for community health workers

Anemia in pregnancy is a key risk VytalBridge's maternal monitoring targets, and its Doctor Hub prioritises patients by clinical risk with offline sync for community health workers. Embedding NiADA gives VytalBridge a risk signal and Monere an African maternal-health use case.

25%confidence

Evidence from the records

  • “VytalBridge is a maternal health monitoring platform in development (Eswatini/Botswana)”
  • “AI-based non-invasive anemia screening in a few seconds, without a blood test.”
If it works
A joint grant-fundable maternal-health package.
First step
Propose a joint grant application to a maternal-health funder.

Investors2

A fund whose thesis fits

US angel network for health AI

Robin Hood Ventures invests $0.25–0.5M at pre-seed/seed in US HealthTech and AI, matching Monere's stage, and backed network member Vytala Health, a warm intro route.

20%confidence

Evidence from the records

  • “MIT Solve selection”
  • “Too early.”
If it works
A first priced pre-seed round to fund validation.
First step
Ask Vytala Health's CEO for an intro after the validation protocol is defined.

Global health-equity accelerator

StartUp Health backs pre-seed/seed HealthTech globally and supported network member Wink Biotherapeutics; Monere's health-equity angle (MIT Solve Global Health Equity) aligns.

20%confidence

Evidence from the records

  • “MIT Solve 2024 selection (30/2,200)”
  • “Real problem”
If it works
Access to health-system pilots and investor network.
First step
Apply to StartUp Health with the MIT Solve credential and an evidence plan.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai

Most promising across the network

587 opportunities analysed
  1. Critical Medical DeviceswithLove LifesciencesPeers
    Share drug-delivery device lessons with Love Lifesciences

    Both are US pre-seed drug-delivery device companies founded around a clinical pain point. Exchanging contract manufacturer, regulatory consultant and pharma-partnering contacts saves both time and money.

    30%
  2. Roam TechnologieswithByonyksPeers
    Learn from Byonyks' 2025 FDA class II clearance and US launch set-up

    Byonyks obtained FDA 510(k) clearance for a home-therapy device and is setting up US infrastructure, the exact path Roam must follow. A founder exchange can shorten Roam's regulatory and DME launch planning.

    30%
  3. Lampsy HealthwithLegit.HealthPeers
    Learn from Legit.Health's medical-device certification path

    Legit.Health took an AI medical device through CE marking with an ISO 13485 quality system in Iberia; Lampsy faces the same regulatory steps. A founder exchange shortens the learning curve.

    30%
  4. AlgatekwithAtoz Carbon Cycle PlatformPeers
    Regional microalgae alliance for Malaysia

    Atoz builds nature-based carbon solutions with microalgae in Malaysia but has no public traction; Algatek has installed units at Indonesian SOEs. Sharing technology, MRV methods and possibly licensing Algatek units into Malaysia would give both a bigger regional story.

    25%
  5. Learn from a deployed microalgae business next door

    Algatek has leased microalgae units to Indonesian SOEs and claims IoT-monitored capture; Atoz has a prototype. Licensing or co-selling Algatek's MicroForest in Malaysia could give Atoz an immediate product while it builds its platform.

    25%
  6. Love LifescienceswithCritical Medical DevicesPeers
    Share FDA and QMS learnings between two pre-clearance drug-delivery devices

    Both companies are pre-FDA drug-delivery device makers founded by clinicians. Sharing regulatory consultants, QMS templates and test labs reduces cost for both.

    25%
  7. ZymoChemwithYeast Bay BioPeers
    Davis fermentation network and scale-up playbook

    ZymoChem's CEO trained at UC Davis, where Yeast Bay Bio was founded in 2025. Sharing contract-fermentation contacts, scale-up lessons and DOE/grant experience is low cost and high value for a seed-stage fermentation company.

    25%
  8. LainTechwithBaniqlPeers
    Battery-metals alliance between two atmospheric leaching processes

    Baniql produces battery-grade nickel MHP from Indonesian laterites at low temperature and pressure; Lain Tech treats sulfides containing cobalt and nickel. Together they can present battery offtakers a complementary low-carbon hydrometallurgy portfolio and share know-how on catalysts and scale-up.

    25%
  9. Amass BiosystemswithRegenratePeers
    Borrow Regenrate’s contract-farming model for intercrops

    Regenrate monetises the intercrop period in France with free seed and guaranteed purchase prices — the same farmer-economics problem Amass must solve. Its contract design is a template for Amass' farmer offer.

    20%
  10. BILIXwithPleryon TherapeuticsPeers
    Exchange on polymer-drug CMC and Asian licensing

    Both companies develop polymer-based therapeutics at Series A in Asia. Sharing CMC suppliers, regulatory strategy and licensing contacts reduces cost and time for both.

    20%
  11. Pleryon TherapeuticswithBioSapienPeers
    Compare local-delivery regulatory playbooks

    Both companies build localised, extended-release delivery platforms (BioSapien in oncology implants, Pleryon in ophthalmology). Sharing regulatory and CMC learnings on biodegradable delivery systems reduces costly missteps.

    20%
  12. RegenratewithAmass BiosystemsPeers
    Exchange intercrop-for-bioenergy playbooks

    Amass grows a bioenergy crop alongside corn for biomass; Regenrate grows camelina between crops for biofuel. Both sell farmer income diversification to energy buyers and can share off-take and agronomy learnings across EU/US.

    20%
  13. FluvwithTausiPeers
    Share the gig-provider OS playbook

    Tausi runs an AI-powered operating system for independent beauticians with verified providers and a commission model. Fluv faces the same supply-side problem with pet-sitters; exchanging verification, training and retention practices is useful for both.

    15%
  14. PromptendwithNeurath AIPeers
    AI reliability peer exchange

    Both address trust in AI outputs (Promptend for generated code, Neurath for model predictions) and sell to risk-averse engineering buyers; sharing go-to-market learnings on assurance products is useful.

    15%
  15. PsychoTechwithPromptendPeers
    Moldovan finalist cohort coordination

    Both represent Moldova at the SWC final; pooling travel, investor meetings and Startup Moldova support reduces cost, and PsychoTech could pilot Promptend on its client code.

    15%
  16. ShopperoowithPardon AIPeers
    Benchmark against Pardon AI's profitability agents

    Pardon AI sells AI agents that optimise revenue and margins for retail and food service and has been through Techstars. A founder exchange clarifies positioning and possible specialisation (pricing/assortment vs broader profitability).

    15%
  17. VIEROC AIwithWiseUnitPeers
    Exchange voice-agent and chat-agent learnings with WiseUnit

    WiseUnit sells an AI phone receptionist; VIEROC focuses on chat agents. Comparing pricing, churn and model costs, or white-labelling each other's channel, could help both small teams.

    15%
  18. SchoolACEwithKetzaiPeers
    Learn from Ketzai’s path to 40,000 teachers

    Ketzai solved teacher acquisition for AI lesson planning by aligning with official curricula; SchoolACE can learn its playbook and potentially share content tooling for Spanish-speaking US classrooms.

    15%

Similar profiles

Compatibility score with Monere Ai

Scored on needs and offers, market bridge, customer potential, sector synergy and stage. Open a profile to see each dimension.